Maurice W. Dysken, MD; Mary Sano, PhD; Sanjay Asthana, MD; et al.
In a double-blind, placebo-controlled, parallel-group, randomized clinical trial with 613 patients, Dysken and coauthors investigated the use of vitamin E (alpha tocopherol), memantine, and a combination to slow progression of mild to moderate Alzheimer disease (AD). In an Editorial, Evans and coauthors discuss the best features in trials of AD therapy and a balance between treatment and prevention.
-
Editorial
Vitamin E, Memantine, and Alzheimer Disease
Denis A. Evans, MD; Martha Clare Morris, ScD; Kumar Bharat Rajan, PhD
JAMA